In the case of Phamaxis, your "seed" did not grow very well.
I think the report proved again, that the drug cannot receive enough revenue to cover the cost, the cash is quickly reducing and the outcome of next trail is years away.
What a shame they put the words "strong sales" in the report, anyone with basic balance sheet knowledge can tell that the cash burning is a big worry.
why bronchitol is so good!!!! , page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.13M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $145.4K | 5.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1763138 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 235590 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |